CCL24



CCL24

V1VV1V2VV2I3II3P4PP4S5SS5P6PP6C7CC7C8CC8M9MM9F10FF10F11FF11V12VV12S13SS13K14KK14R15RR15I16II16P17PP17E18EE18N19NN19R20RR20V21VV21V22VV22S23SS23Y24YY24Q25QQ25L26LL26S27SS27S28SS28R29RR29S30SS30T31TT31C32CC32L33LL33K34KK34A35AA35G36GG36V37VV37I38II38F39FF39T40TT40T41TT41K42KK42K43KK43G44GG44Q45QQ45Q46QQ46F47FF47... and 46 more residue(s)...... and 46 more residue(s)

SMILES None
InChIKey None
Sequence VVIPSPCCMFFVSKRIPENRVVSYQLSSRSTCLKAGVIFTTKKGQQFCGDPKQEWVQRYMKNLDAKQKKASPRARAVAVKGPVQRYPGNQTTC

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL24

V1VV1V2VV2I3II3P4PP4S5SS5P6PP6C7CC7C8CC8M9MM9F10FF10F11FF11V12VV12S13SS13K14KK14R15RR15I16II16P17PP17E18EE18N19NN19R20RR20V21VV21V22VV22S23SS23Y24YY24Q25QQ25L26LL26S27SS27S28SS28R29RR29S30SS30T31TT31C32CC32L33LL33K34KK34A35AA35G36GG36V37VV37I38II38F39FF39T40TT40T41TT41K42KK42K43KK43G44GG44Q45QQ45Q46QQ46F47FF47... and 46 more residue(s)...... and 46 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.